Enabling Technology. (i) It is understood that the licenses set forth in (P)3.2B
(a) include a license, with the right to grant and authorize sublicenses, under PIONEER's interest in the Enabling Technology to make, have made, sell, have sold, import, use, and have used MAXYGEN Licensed Products incorporating Enabling Technology, together with Shuffled Genes (excluding [*******]) in the MAXYGEN Crops in accordance with such license, but does not include a license to [*******]
(ii) In the event that PIONEER and MAXYGEN mutually agree in writing pursuant to (P)2.7D upon an appropriate royalty or other value capture mechanism for other uses of Enabling Technology by MAXYGEN [*******], PIONEER will grant to MAXYGEN a nonexclusive, royalty-bearing, worldwide license for such uses of the applicable Enabling Technology.
Enabling Technology. It is understood and agreed to by Aridis that Project Intellectual Property and the underlying Background Intellectual Property as licensed to PVS by Aridis hereunder shall be used by PVS for the advancement of the Primary Formulation and/or the Optional Formulation developed by Aridis under the Project Plan and shall be made available in accordance with Article 5 to PVS designated manufacturers for the advancement of a Rotavirus Vaccine in Developing Countries.
4.2.1 Information, reagents and materials, including but not limited to (a) qualified cell lines, (b) production processes and formulations, (c) assay design and reagents, and (d) packaging design, some or all of which may be made available to Aridis by PVS or its designees or, in the case of a formulation, developed by Aridis under the Project Plan is defined as “Enabling Technology.”
4.2.2 Should Aridis elect to develop and manufacture a Rotavirus Vaccine, PVS shall, upon such written notification from Aridis and to the extent reasonable based on good faith negotiations by the Parties, provide Aridis with access to Enabling Technology with the right to use such Enabling Technology in the commercial development of a Rotavirus Vaccine. Acceptance and use of Enabling Technology shall obligate Aridis to the global access provisions as set forth in Article 6.
Enabling Technology. 2 1.14 FDA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 1.15 GAAP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 1.16 GLP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 1.17 GMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 1.18
Enabling Technology. A. The parties anticipate that the development of products within the Trait Categories may be significantly enhanced by the application of Shuffling Technology in the area of Enabling Technology. Unless mutually agreed in writing, application of Shuffling Technology for development of Enabling Technology will only be undertaken pursuant to the R&D Program and relating to at least one Trait Category upon mutual agreement of the parties and inclusion in the Work Plan. It is understood that any effort to develop Enabling Technology shall be undertaken on a case-by-case basis, based on a written project description which describes the specific starting materials and goals and the successful outcome(s).
B. At such time as a party proposes that a project be conducted for the development of Enabling Technology, it shall inform, to the extent it is able to do so without breaching any confidentiality obligations, the RDSC of all rights which it has with respect to the underlying technology on which such Enabling Technology will be based or will require, including without limitation, any rights it has to use and sublicense such underlying technology, and any restrictions or limitations thereon, and any information of which it is aware with respect to third party patent applications or patents which may relate to the use of the proposed Enabling Technology in the R&D Program and/or for the development or commercialization of Licensed Products; provided, neither party shall have any obligation to provide the RDSC with any document which would result in a breach of the attorney/client privilege with respect thereto. The RDSC shall have the sole authority to authorize the conduct and scope of projects in the R&D Program intended to produce Enabling Technology. If the RDSC cannot agree on a particular Enabling Technology project, the matter shall be resolved as provided for in (P)13.1A.
C. Prior to such time as the RDSC approves the conduct of research relating to any Enabling Technology, the parties shall negotiate in good faith the rights, if any, which (i) PIONEER shall have to use such Enabling Technology other than [*******], and/or (ii) MAXYGEN shall have to use such Enabling Technology other than [*******]. In the event the parties fail to reach agreement on such rights, the only rights that PIONEER and MAXYGEN shall have to use the applicable Enabling Technology are those set forth in (P)3.1C and (P)3.2C below, respectively.
D. Prior to commencing research with r...
Enabling Technology. Except for use in connection with the R&D ------------------- Program or as expressly permitted pursuant to the licenses in (P)3.1B and C and 3.2B and C, PIONEER or MAXYGEN shall not have any right to use or disclose Enabling Technology to any third party.
Enabling Technology. The following well-known technologies have been selected to manage the PARTHENOS e- infrastructure hardware resources:
a. Ceph, xxxx://xxx.xxxx.xxx, has been selected as block storage since it is Amazon S3 compatible and OpenStack Swift compatible, it is completely distributed, and it may even use disposable server hardware;
b. Openstack, xxxx://xxx.xxxxxxxxx.xxx, has been selected as cloud-computing software platform. It uses Ceph as storage;
c. ManageIQ, xxxx://xxxxxxxx.xxx, has been selected to manage quotas, permissions, production vs. development environments. The Ceph Storage offers object, block, and file storage under a unified system. It has been designed to provide excellent performance, reliability and scalability. It supports rapid provisioning of massively scalable cloud storage and enables computationally intensive workloads. It provides access to the storage via application written in Java, Python, Ruby, C, etc. It scales to Petabytes and it offers linear scaling with linear performance increase. The ManageIQ open source platform is a management framework for infrastructure integrating resources from several data centres. It has been designed to manage small and large infrastructure, and supports private data centres exploiting virtual machines and even public clouds. ManageIQ supports continuous monitoring of the latest state of the infrastructure, simplifies the enforcement of policies across the environment, and it optimizes the performance and utilization of the hardware resources.
Enabling Technology. Bayer and its Affiliates shall be entitled to make improvements, modifications, enhancements and changes to the Enabling Technology (individually and/or collectively, the “Bayer Improvements”). Bayer and/or its Affiliates, as applicable, shall own the Bayer Improvements and shall have no obligation to assign and/or license any Bayer Improvements to Maxygen and/or any of its Affiliates.
Enabling Technology. 15.1 We reserve the right to install Enabling Technology on Goods that are capable of connecting to the Internet.
15.2 The Enabling Technology is built into the hardware of the Goods and cannot be disabled, and its function cannot be distinguished or isolated from the operation of the Goods.
15.3 You acknowledge and agree that we may use the Enabling Technology if there is an Event of Default and that we may:
(a) use the Enabling Technology to disable the device and render it inoperative or otherwise restrict its full functionality;
(b) use the Enabling Technology to send a message to you or the person in possession of the Goods;
(c) use the Enabling Technology to locate the whereabouts of the Goods.
15.4 We will not use the enabling technology:
(a) in any circumstance unless there is an Event of Default;
(b) to view any of your information on the Goods;
(c) to use any information on the device;
(d) to transmit or install any information or data on the device; or
(e) to gain access to any photos stored on the device or to any camera installed.
15.5 If the Goods are blocked, the Goods cannot be used to access mobile services except to make emergency call.
Enabling Technology. (i) It is understood that the license set forth in (P)3.1B includes a license, with the right to grant sublicenses, to make, have made and use the Enabling Technology to develop, make, have made, use, offer for sale, sell and have sold PIONEER Licensed Products incorporating Shuffled Genes (excluding [*******]) in the applicable Trait Categories in the PIONEER Crops in accordance with such license, but does not include a license to [*******]
(ii) In the event that PIONEER and MAXYGEN mutually agree in writing pursuant to (P)2.7D upon an appropriate royalty or other value capture mechanism for other uses of Enabling Technology by PIONEER [*******], MAXYGEN will grant to PIONEER a nonexclusive, royalty- bearing, worldwide license for such uses of the applicable Enabling Technology.
Enabling Technology. 24 8.4 Rights to Collxxx Xxxtent............................................................. 24 8.5 Rights to Sierra Multimedia Components................................................ 24 8.6 Company Technology.................................................................... 25 8.7 Continuation of Use................................................................... 25 8.8 Use of Other Member's Name............................................................ 25 8.9
